Search for Food & Drug Administration USA and
    1. December 10, 2014

      Signs of a revival in drug development

      After a long innovation drought in the previous decade, investors in big pharma would be forgiven for wondering whether...

    2. December 10, 2014

      Electrical pulses could replace many traditional medicines

      Imagine a world in which health disorders could be treated by an implantable device that “speaks” the electronic language of...

    Special Reports

    1. Combating Hepatitis C

      Treatment for the virus is in the midst of its biggest advance for at least a decade a...
    2. Innovation in Healthcare

      Healthcare has been slower than other industries to feel the full force of digital tec...
    Search more Special Reports on this topic.

    1. December 8, 2014

      Superbug threat drives $9.5bn Merck deal

      The growing threat from deadly superbugs prompted Merck to spend about $9.5bn including debt to buy Cubist, the US biotech...

    2. November 19, 2014

      Ranbaxy sues US FDA for revoking drug approvals

      Ranbaxy, the troubled Indian drugmaker, is suing the US Food and Drug Administration for revoking its tentative approvals to...

    3. October 3, 2014

      Guinter Kahn, dermatologist, 1934-2014

      Scientists have been seeking a cure for baldness since the dawn of modern medicine. Hippocrates experimented with a...

    4. September 14, 2014

      Novo Nordisk says US more open to obesity drugs

      US regulators are becoming more open to drugs for tackling obesity, says the chief executive of Novo Nordisk, as the Danish...

    5. July 27, 2014

      Hepatitis C researchers battle to ‘nuke’ the competition

      Idenix has fewer than 100 employees and no products on the market. So what was it that persuaded Merck to pay $3.85bn – more...

    6. June 13, 2014

      Shire to test ADHD drug on pre-school children

      Shire is to begin testing its amphetamine-based drug for attention deficit hyperactivity disorder in pre-school children, in...

    7. May 18, 2014

      Side-effects prompt calls to cut use of sleeping pills

      More than 60m prescriptions a year are issued for sleeping pills in the US, generating billions of dollars for the...

    8. May 16, 2014

      Pfizer seeks breast cancer drug approval

      Pfizer is to file for regulatory approval for an important new breast cancer drug in the third quarter, the US drugmaker...

    9. April 24, 2014

      US e-cigarette groups embark on extra marketing

      Ronald Reagan, Marlene Dietrich and the Marlboro Man were once the faces of US tobacco. Now a new generation of celebrity...

    10. April 2, 2014

      Ameriprise buoyed by hopes of higher rates

      Ameriprise Financial climbed on Wednesday after analysts at Morgan Stanley lifted their rating on the firm to ‘overweight’...

    11. March 13, 2014

      India’s Sun Pharma shares sink on US FDA import ban

      Shares in Sun Pharmaceutical Industries, India’s largest drugmaker by market capitalisation, shed as much as 6.4 per cent on...

    12. March 6, 2014

      FDA warns India on drugs standards

      America’s top drugs watchdog has urged New Delhi to work with US regulators to help raise standards in the Indian...

    13. March 5, 2014

      ‘Cut the sugar’ WHO warns in new guidelines

      One can of regular cola. Or one Mars bar. But not both in one day. Under proposed new health guidelines from the World...

    14. February 27, 2014

      US to overhaul nutrition labels on food

      The Obama administration on Thursday unveiled an overhaul of food nutrition labels that has been more than a decade in the...

    15. February 6, 2014

      Dallas Buyers Club – film review

      Cinema is a place of weird transactions. Filmgoers part with dozens of pounds for the pleasure of eyeballing actors who have...

    16. January 24, 2014

      Ranbaxy shares sink on US FDA product ban

      Shares in Ranbaxy, the troubled Indian pharmaceutical company, plunged 20 per cent after the US banned imports from a fourth...

    17. November 27, 2013

      US bans drug imports from Wockhardt factory

      Shares in Wockhardt, the Indian generics drug producer, dropped more than 13 per cent on Wednesday morning after the US...

    18. November 26, 2013

      Start-ups: regulating expectations

      Start-ups would save the human race if only the Luddite regulators – probably still typing on BlackBerrys – would just get...

    19. November 26, 2013

      DNA test company told to stop selling kits

      23andMe, a DNA testing company that came to symbolise Silicon Valley’s ambition of grabbing a leading position in the...

    20. November 7, 2013

      US regulators move to cut trans fats out of national diet

      US food regulators want to all but ban trans fats, once ubiquitous in fast food and packaged snacks, in the culmination of...

    21. November 4, 2013

      Biotech stock boom risks becoming bubble

      In this year’s record-breaking bull run for US stocks, one industry in particular has been a standout performer....

    22. September 16, 2013

      Ranbaxy shares fall as US says it will seize drugmaker’s imports

      Shares in the Indian generic drugmaker Ranbaxy plunged more than 30 per cent after the US Food and Drug Administration...

    23. September 10, 2013

      GlaxoSmithKline under pressure over threat of US Advair generic

      GlaxoSmithKline’s shares came under pressure on Tuesday after US regulators issued draft guidelines raising the prospect of...

    24. beyondbrics

      August 7, 2013

      Ranbaxy: no help from the rupee

      embed2 News about Ranbaxy this quarter has been generally iffy: guilty verdicts and drops in share price. But poor figures...

    25. July 28, 2013

      S1 Biopharma starts trial of female libido drug

      A new drug called Lorexys, which aims to rekindle sexual desire in women, is beginning a clinical trial in the US. Its...

    26. beyondbrics

      July 25, 2013

      US drug inspectors take Indian generics maker to task

      Shares in Wockhardt, an Indian generics producer, dropped 3.2 per cent on Thursday, adding to a 20 per cent drop on...

    27. July 23, 2013

      US eyes curbs on menthol cigarettes

      US regulators are considering limiting the sale of menthol cigarettes after concluding that the minty-flavoured products may...

    28. June 6, 2013

      Big Tobacco bets a packet on e-cigarettes

      Big Tobacco in the US is raising its bet on the growth of electronic cigarettes to offset the decline of traditional smoking...

    29. beyondbrics

      May 23, 2013

      India's Ranbaxy: another can of worms

      Last week Ranbaxy Laboratories, India’s biggest pharmaceuticals company, must have thought it had at last settled an...

    30. May 1, 2013

      Novo Nordisk/Lundbeck: drugs start working

      The news from Denmark’s sizeable pharmaceuticals sector has been suitably Nordic noir recently. H Lundbeck, beset by patent...

    31. February 28, 2013

      US investigates robotic surgical devices

      Shares of Intuitive Surgical fell 11 per cent on Thursday after reports that the US Food and Drug Administration is...

    32. February 25, 2013

      Reckitt Benckiser: motorcycle maintenance

      Like a motorcycle attached to a creaky sidecar, Reckitt Benckiser is being dragged back by something it does not really...

    33. February 14, 2013

      US regulator approves first bionic eye

      Millions of blind people will be able to regain limited sight after the world’s first “bionic eye” was approved by US...

    34. February 11, 2013

      Novo Nordisk: reality check

      There goes the visibility premium. Novo Nordisk has stood out from rivals in recent years because its growth has been so...

    35. February 11, 2013

      FDA rejects Novo Nordisk insulin remedy

      Novo Nordisk lost DKr80bn from its stock market value after the Danish drugs company failed to win US regulatory approval...

    36. January 23, 2013

      Allergan adds MAP to migraine plans

      Allergan, the US maker of Botox, said late on Tuesday that it has acquired MAP Pharmaceuticals in a $958m deal that will...

    37. January 17, 2013

      Lawmakers demand data on energy drinks

      US lawmakers stepped up their investigation into energy drinks on Thursday, demanding that companies making products such as...

    38. January 10, 2013

      FDA examines pain pill formula regulation

      The US Food and Drug Administration has said it will force generic manufacturers of powerful pain pills to use new...

    Search for Food & Drug Administration USA and